← 返回专利悬崖列表




苹果酸舒尼替尼
Tier B · 提前布局Sunitinib Malate
辉瑞
原研
2006
首批上市
-
到期年(公开口径)
$1.24B ▲
峰值销售
化学药
类型
靶点:VEGFR1、KIT、VEGFR3、CSF1R、PDGFR-β、VEGFR2、FLT3、PDGFR-α、RET
商品名:Sutent、索坦
适应症(已批准):胰腺神经内分泌肿瘤、肾细胞癌、胃肠道间质瘤
各地区研发/上市状态
美国
批准上市
2006-01-26
欧盟
批准上市
2006-07-19
中国
批准上市
2007-10-30
日本
批准上市
2008-04-16
合成路线与中间体5 routes
原研路线 × 1优化路线(非专利)× 3工艺路线 × 1
路线按「原研路线 → 优化路线 / 工艺路线(非专利)」排序。每条路线附本站自绘的路线流程图(中间体 → 原料药)与中间体表(编号 / CAS / 英文名),可直接用于供应商开发与询价。流程图由本站依据已授权的结构化数据自行渲染,未使用任何第三方路线图。
原研Route 1步骤 6 · 总收率 216 g

| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| SUNT-001 | 674-82-8在售 | 4-methyleneoxetan-2-one |
| SUNT-002 | 100-36-7在售 | N1,N1-diethylethane-1,2-diamine |
| SUNT-003 | 590424-03-6在售 | N-(2-(diethylamino)ethyl)-3-oxobutanamide |
| SUNT-004 | 1694-31-1在售 | tert-butyl 3-oxobutanoate |
| SUNT-005 | 590424-04-7在售 | tert-butyl 4-((2-(diethylamino)ethyl)carbamoyl)-3,5-dimethyl-1H-pyrrole-2-carboxylate |
| SUNT-006 | 590424-05-8在售 | N-(2-(diethylamino)ethyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide |
| SUNT-007 | 3724-43-4在售 | N-(chloromethylene)-N-methylmethanaminium chloride |
| SUNT-008 | 356068-86-5在售 | N-(2-(diethylamino)ethyl)-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide |
| SUNT-009 | 56341-41-4在售 | 5-fluoroindolin-2-one |
| SUNT-010 | 97-67-6在售 | (S)-2-hydroxysuccinic acid |
优化Route 3步骤 3 · 总收率 /

| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| SUNT-002 | 100-36-7在售 | N1,N1-diethylethane-1,2-diamine |
| SUNT-006 | 590424-05-8在售 | N-(2-(diethylamino)ethyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide |
| SUNT-014 | 2199-51-1在售 | ethyl 2,4-dimethyl-1H-pyrrole-3-carboxylate |
| SUNT-017 | 17106-13-7在售 | 2,4-dimethyl-1H-pyrrole-3-carboxylic acid |
| SUNT-018 | 52508-87-9在售 | 5-fluoro-2-oxoindoline-3-carbaldehyde |
优化Route 4步骤 8 · 总收率 0.6 g

| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| SUNT-002 | 100-36-7在售 | N1,N1-diethylethane-1,2-diamine |
| SUNT-008 | 356068-86-5在售 | N-(2-(diethylamino)ethyl)-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide |
| SUNT-012 | 141-97-9在售 | ethyl 3-oxobutanoate |
| SUNT-014 | 2199-51-1在售 | ethyl 2,4-dimethyl-1H-pyrrole-3-carboxylate |
| SUNT-015 | 2199-59-9在售 | ethyl 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylate |
| SUNT-016 | 253870-02-9在售 | 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid |
| SUNT-019 | 2436-79-5在售 | diethyl 3,5-dimethyl-1H-pyrrole-2,4-dicarboxylate |
| SUNT-020 | 5442-91-1在售 | 4-(ethoxycarbonyl)-3,5-dimethyl-1H-pyrrole-2-carboxylic acid |
| SUNT-021 | 1257262-45-5在售 | diethyl (2-((4-fluoro-2-iodophenyl)amino)-2-oxoethyl)phosphonate |
| SUNT-022 | 1257262-48-8在售 | (Z)-N-(2-(diethylamino)ethyl)-5-(3-((4-fluoro-2-iodophenyl)amino)-3-oxoprop-1-en-1-yl)-2,4-dimethyl-1H-pyrrole-3-carboxamide |
| SUNT-023 | 61272-76-2在售 | 4-fluoro-2-iodoaniline |
| SUNT-024 | 79-04-9在售 | 2-chloroacetyl chloride |
| SUNT-025 | 1257262-44-4在售 | 2-chloro-N-(4-fluoro-2-iodophenyl)acetamide |
| SUNT-026 | 122-52-1在售 | triethyl phosphite |
优化Route 5步骤 6 · 总收率 12 g

| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| SUNT-002 | 100-36-7在售 | N1,N1-diethylethane-1,2-diamine |
| SUNT-009 | 56341-41-4在售 | 5-fluoroindolin-2-one |
| SUNT-010 | 97-67-6在售 | (S)-2-hydroxysuccinic acid |
| SUNT-012 | 141-97-9在售 | ethyl 3-oxobutanoate |
| SUNT-015 | 2199-59-9在售 | ethyl 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylate |
| SUNT-019 | 2436-79-5在售 | diethyl 3,5-dimethyl-1H-pyrrole-2,4-dicarboxylate |
| SUNT-020 | 5442-91-1在售 | 4-(ethoxycarbonyl)-3,5-dimethyl-1H-pyrrole-2-carboxylic acid |
| SUNT-027 | 951661-94-2在售 | ethyl (Z)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxylate |
工艺Route 2步骤 8 · 总收率 1.7 kg

| 编号 | CAS 号 | 中间体名称 |
|---|---|---|
| SUNT-002 | 100-36-7在售 | N1,N1-diethylethane-1,2-diamine |
| SUNT-004 | 1694-31-1在售 | tert-butyl 3-oxobutanoate |
| SUNT-008 | 356068-86-5在售 | N-(2-(diethylamino)ethyl)-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide |
| SUNT-009 | 56341-41-4在售 | 5-fluoroindolin-2-one |
| SUNT-010 | 97-67-6在售 | (S)-2-hydroxysuccinic acid |
| SUNT-011 | 14352-65-9在售 | (E)-tert-butyl 2-(hydroxyimino)-3-oxobutanoate |
| SUNT-012 | 141-97-9在售 | ethyl 3-oxobutanoate |
| SUNT-013 | 86770-31-2在售 | 2-(tert-butyl) 4-ethyl 3,5-dimethyl-1H-pyrrole-2,4-dicarboxylate |
| SUNT-014 | 2199-51-1在售 | ethyl 2,4-dimethyl-1H-pyrrole-3-carboxylate |
| SUNT-015 | 2199-59-9在售 | ethyl 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylate |
| SUNT-016 | 253870-02-9在售 | 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid |
常见问题(FAQ)
苹果酸舒尼替尼的适应症有哪些?
已批准的适应症包括:胰腺神经内分泌肿瘤、肾细胞癌、胃肠道间质瘤。
苹果酸舒尼替尼的专利什么时候到期?
苹果酸舒尼替尼的专利到期年暂无公开口径,本页会在数据管道核实后更新。
苹果酸舒尼替尼有几条合成路线?
本站收录 5 条合成路线,最短路线 3 步、总收率 /。每条路线的中间体均带登记编号与 CAS 号。
苹果酸舒尼替尼的关键中间体在哪里可以采购?
苹果酸舒尼替尼的多条路线中间体已挂接 CAS 档案,其中 27 个 CAS 已有优贝德(Unibest)供应网络在售报价,可在本页路线表中直接查看并询价。
如何获取苹果酸舒尼替尼中间体的报价?
在本页选择目标中间体的 CAS 进入档案页,或在询价页直接提交需求;CAS 会自动带入供需撮合流程,由供应网络反馈报价。
数据来源:多源数据交叉核实(仅结构化字段) · 2026-09-24